Priority Applications (16) Applications Claiming Priority (10) Related Child Applications (2) Publications (2) Family ID=50488881 Family Applications (1) Country Status (17) Cited By (60) Families Citing this family (12) Family Cites Families (215) 2013 2013-10-15 BR BR112015008365A patent/BR112015008365A2/en not_active IP Right Cessation 2013-10-15 IN IN4147DEN2015 patent/IN2015DN04147A/en unknown 2013-10-15 JP JP2015537776A patent/JP2015536323A/en active Pending 2013-10-15 AU AU2013331440A patent/AU2013331440A1/en not_active Abandoned 2013-10-15 SG SG11201502896XA patent/SG11201502896XA/en unknown 2013-10-15 EP EP13846566.1A patent/EP2908818A4/en not_active Withdrawn 2013-10-15 US US14/435,919 patent/US9662402B2/en not_active Expired - Fee Related 2013-10-15 CA CA2887727A patent/CA2887727A1/en not_active Abandoned 2013-10-15 WO PCT/US2013/065079 patent/WO2014062697A2/en not_active Ceased 2013-10-15 KR KR1020157012634A patent/KR20150070318A/en not_active Withdrawn 2013-10-15 EA EA201590622A patent/EA201590622A1/en unknown 2013-10-15 CN CN201380059463.9A patent/CN104869998A/en active Pending 2013-10-15 MX MX2015004757A patent/MX2015004757A/en unknown 2013-10-15 HK HK16100611.1A patent/HK1212618A1/en unknown 2013-10-16 TW TW102137361A patent/TW201417833A/en unknown 2013-10-16 AR ARP130103759A patent/AR093038A1/en unknown 2015 2015-04-15 IL IL238301A patent/IL238301A0/en unknown 2017 2017-03-09 US US15/454,109 patent/US20170360950A1/en not_active Abandoned 2019 2019-08-23 US US16/549,247 patent/US20200121801A1/en not_active Abandoned
Prior JC
Muscle weakness, cramps, or spasmsparticularly in the legssuggest hypokalemia or hypomagnesemia
Stack: Retatrutide: Research-dose titration (start low, escalate gradually per Phase 2 trial protocol) Ipamorelin/CJC-1295: 100-200mcg pre-sleep daily Why this combination works: Retatrutide targets the GLP-1, GIP, and glucagon receptors to suppress appetite, improve insulin sensitivity, and drive fat oxidation
Sugar free, soy free, no heat or solvents
